Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11129906 | 0.82 | HDAC4 (0.30) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL10662824 | 0.76 | FFAR1 (0.33) | SMN1; SMN2 | |
| SCHEMBL5706273 | 0.76 | ALDH1A1 (0.31) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL873077 | 0.76 | ALDH1A1 (0.31) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL27496666 | 0.75 | GPR84 (0.31) | SMN1; SMN2 | |
| SCHEMBL4316160 | 0.74 | SMN1; SMN2 (0.33) | SMN1; SMN2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL28691112 | 0.74 | — | — | |
| SCHEMBL9772140 | 0.73 | LNPEP (0.31) | SMN1; SMN2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL11615938 | 0.72 | PTGS1 (0.38) | SMN1; SMN2HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL634692 | 0.71 | HDAC4 (0.38) | SMN1; SMN2HDAC4HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113651692-A | Preparation method of tricyclodecenyl ester | 广东希必达新材料科技有限公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-111249913-A | Processing biomass | 希乐克公司 | 2020-06-09 | — | — | CN | disclosed |
| CN-111229043-A | Processing biomass | 希乐克公司 | 2020-06-05 | — | — | CN | disclosed |
| US-8383574-B2 | Perfume composition | KAO CORPORATION (JP) | 2013-02-26 | — | — | US | disclosed |
| EP-2253695-B1 | PERFUME COMPOSITION | KAO CORP (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110071070-A1 | PERFUME COMPOSITION | KAO CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-2253695-A1 | PERFUME COMPOSITION | Kao Corporation (JP) | 2010-11-24 | — | — | EP | disclosed |
| EP-2046718-B1 | PROCESS FOR MAKING TRICYCLODECENYL ESTERS | MILLENNIUM SPECIALTY CHEM INC (US) | 2010-04-21 | — | — | EP | disclosed |
| EP-2155652-A1 | PROCESS FOR MAKING TRICYCLODECENYL ESTERS | Millennium Specialty Chemicals, Inc. (US) | 2010-02-24 | — | — | EP | disclosed |
| EP-1380559-B1 | Ethers of 2,2,4-trimethylpentane-1, 3-diol as fragrance materials | TAKASAGO PERFUMERY CO LTD (JP) | 2009-12-23 | — | — | EP | disclosed |
| EP-2046718-A2 | PROCESS FOR MAKING TRICYCLODECENYL ESTERS | Millennium Specialty Chemicals, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008153658-A1 | PROCESS FOR MAKING TRICYCLODECENYL ESTERS | MILLENNIUM SPECIALTY CHEMICALS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-7446221-B1 | Process for making tricyclodecenyl esters | EQUISTAR CHEMICALS, LP (US) | 2008-11-04 | — | — | US | disclosed |
| US-20080021235-A1 | Process for making tricyclodecenyl esters | PINOVA HOLDINGS, INC | 2008-01-24 | — | — | US | disclosed |
| WO-2008010910-A2 | PROCESS FOR MAKING TRICYCLODECENYL ESTERS | MILLENNIUM SPECIALTY CHEMICALS, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| US-7132391-B2 | Ethers of 2,2,4-trimethylpentane-1,3-diol as fragrance materials | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-11-07 | — | — | US | disclosed |
| EP-1380559-A1 | Ethers of 2,2,4-trimethylpentane-1, 3-diol as fragrance materials | Takasago International Corporation (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071070-A1 | PERFUME COMPOSITION | C5, C1S, C1R | SMN1; SMN2 4368/4885HDAC4 3093/4885HDAC2 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.